Discover Abbott Practice Solutions for your Cardiometabolic patient management
Chronic cardiometabolic diseases are surging worldwide. For example, there are now over 400 million cases of diabetes — and that number will rise by more than 50% in the next 25 years.1 Although practice guidelines include testing for HbA1c, Lipids and ACR, fewer than 7% of patients are tested at the guideline recommended frequency and only 26.7% of patients are meeting targets for glycemic, blood pressure and cholesterol control.2,3 New, more efficient methods for handling this growing epidemic are needed.
Point-of care tests (POCT), such as rapid diagnostics from Abbott, have been shown to improve patient medical outcomes and practice efficiency.4